158 related articles for article (PubMed ID: 21301920)
1. Steroids and azathioprine in the treatment of IgA nephropathy.
Stangou M; Ekonomidou D; Giamalis P; Liakou H; Tsiantoulas A; Pantzaki A; Papagianni A; Efstratiadis G; Alexopoulos E; Memmos D
Clin Exp Nephrol; 2011 Jun; 15(3):373-380. PubMed ID: 21301920
[TBL] [Abstract][Full Text] [Related]
2. Comparison of glucocorticoids alone and combined with cyclosporine a in patients with IgA nephropathy: a prospective randomized controlled trial.
Liu H; Xu X; Fang Y; Ji J; Zhang X; Yuan M; Liu C; Ding X
Intern Med; 2014; 53(7):675-81. PubMed ID: 24694475
[TBL] [Abstract][Full Text] [Related]
3. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
4. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial.
Ferraro PM; Ferraccioli GF; Gambaro G; Fulignati P; Costanzi S
Nephrol Dial Transplant; 2009 Jan; 24(1):156-60. PubMed ID: 18685141
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
Locatelli F; Pozzi C; Del Vecchio L; Andrulli S; Pani A; Fogazzi G; Altieri P; Ponticelli C
J Nephrol; 1999; 12(5):308-11. PubMed ID: 10630693
[TBL] [Abstract][Full Text] [Related]
7. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
Lv J; Zhang H; Wong MG; Jardine MJ; Hladunewich M; Jha V; Monaghan H; Zhao M; Barbour S; Reich H; Cattran D; Glassock R; Levin A; Wheeler D; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Wang HY; Perkovic V;
JAMA; 2017 Aug; 318(5):432-442. PubMed ID: 28763548
[TBL] [Abstract][Full Text] [Related]
8. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
Eitner F; Ackermann D; Hilgers RD; Floege J
J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
[TBL] [Abstract][Full Text] [Related]
9. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
Moriyama T; Nakayama K; Ochi A; Amemiya N; Tsuruta Y; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of urinary markers predict outcome in IgA nephropathy but their predictive value is influenced by treatment with steroids and azathioprine.
Stangou M; Papagianni A; Bantis C; Moisiadis D; Kasimatis S; Spartalis M; Pantzaki A; Efstratiadis G; Memmos D
Clin Nephrol; 2013 Sep; 80(3):203-10. PubMed ID: 23611517
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive agents for treating IgA nephropathy.
Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
[TBL] [Abstract][Full Text] [Related]
12. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
Pozzi C; Andrulli S; Pani A; Scaini P; Del Vecchio L; Fogazzi G; Vogt B; De Cristofaro V; Allegri L; Cirami L; Procaccini AD; Locatelli F
J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of steroid pulse therapy in patients with IgA nephropathy.
Kim TY; Kim SB; Park SK
Clin Nephrol; 2012 Aug; 78(2):100-5. PubMed ID: 22790453
[TBL] [Abstract][Full Text] [Related]
14. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
Rauen T; Fitzner C; Eitner F; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JFE; Hilgers RD; Floege J
J Am Soc Nephrol; 2018 Jan; 29(1):317-325. PubMed ID: 29042456
[TBL] [Abstract][Full Text] [Related]
15. The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics.
Wong MG; Lv J; Hladunewich MA; Jha V; Hooi LS; Monaghan H; Zhao M; Barbour S; Reich HN; Cattran D; Glassock R; Levin A; Jardine MJ; Wheeler DC; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Zhang H; Perkovic V;
Am J Nephrol; 2021; 52(10-11):827-836. PubMed ID: 34731857
[TBL] [Abstract][Full Text] [Related]
16. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.
Liu LJ; Yang YZ; Shi SF; Bao YF; Yang C; Zhu SN; Sui GL; Chen YQ; Lv JC; Zhang H
Am J Kidney Dis; 2019 Jul; 74(1):15-22. PubMed ID: 30922594
[TBL] [Abstract][Full Text] [Related]
17. Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
Masutani K; Tsuchimoto A; Yamada T; Hirakawa M; Mitsuiki K; Katafuchi R; Hirakata H; Kitazono T; Tsuruya K;
Clin Exp Nephrol; 2016 Dec; 20(6):896-903. PubMed ID: 26758039
[TBL] [Abstract][Full Text] [Related]
18. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
19. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study.
Liang M; Xiong L; Li A; Zhou J; Huang Y; Huang M; Zhang X; Shi H; Su N; Wei Y; Jiang Z
BMC Nephrol; 2022 Jan; 23(1):40. PubMed ID: 35062886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]